Loading…
Loading…
6919.TWO (Caliway Biopharmaceuticals Co., Ltd.) is no longer actively trading.
This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.
6919.TWO does not currently pay a dividend.
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for 6919.TWO and 80,000+ other tickers.
See exactly how 6919.TWO's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 6919.TWO and 80,000+ other tickers.
Caliway Biopharmaceuticals Co., Ltd., established in 2012 and headquartered in New Taipei City, Taiwan, specializes in the development of small-molecule therapeutics designed to address both medical aesthetic and inflammatory conditions.
No recent news available.